EM-T3Expert Opinion on Drug Safety2019-05-04第 18 卷第 5 期，415-425高影响力 · 前 10%
Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice
